Vertex Pharmaceuticals Incorporated (VRTX)

Growth

Revenue 5Y33.40%
Revenue 3Y34.86%
EPS 5Y81.78%
EPS 3Y3.30%
Dividend 5Y-
Dividend 3Y-

Capital Efficiency

ROIC29.45%
ROE28.48%
ROA19.59%
ROTA20.33%

Capital Structure

Market Cap80.93B
EV72.58B
Cash9.17B
Current Ratio4.70
Debt/Equity0.22
Net Debt/EBITDA-1.97
Show More

Income Statement

Select a metric from the list below to chart it

Dec '90
Dec '96
Dec '02
Dec '08
Dec '14
Dec '20
Income Statement
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Revenue
1,212.0
580.4
1,032.3
1,702.2
2,488.7
3,047.6
4,162.8
6,205.7
7,574.4
8,700.6
Revenue % Chg.
-20.6%
-52.1%
77.9%
64.9%
46.2%
22.5%
36.6%
49.1%
22.1%
22.0%
Cost of Revenue
130.3
61.0
124.5
210.5
275.1
409.5
547.8
736.3
904.2
1,044.4
Cost of Revenue % Chg.
-53.5%
-53.2%
104.2%
69.0%
30.7%
48.9%
33.7%
34.4%
22.8%
21.5%
Gross Profit
1,081.7
519.4
907.8
1,491.7
2,213.5
2,638.1
3,615.1
5,469.4
6,670.2
7,656.2
Gross Profit % Chg.
-13.3%
-52.0%
74.8%
64.3%
48.4%
19.2%
37.0%
51.3%
22.0%
22.1%
Gross Profit Margin
89.3%
89.5%
87.9%
87.6%
88.9%
86.6%
86.8%
88.1%
88.1%
88.0%
Gross Profit Margin % Chg.
9.3%
0.3%
-1.7%
-0.3%
1.5%
-2.7%
0.3%
1.5%
-0.1%
0.1%
R&D Expenses
918.8
855.5
995.9
1,047.7
1,324.6
1,416.5
1,754.5
1,829.5
3,051.1
2,542.5
R&D Expenses % Chg.
14.0%
-6.9%
16.4%
5.2%
26.4%
6.9%
23.9%
4.3%
66.8%
-9.9%
Selling, General, & Admin Expenses
362.3
305.4
376.6
432.8
496.1
557.6
658.5
770.5
840.1
932.5
Selling, General, & Admin Expenses % Chg.
-17.0%
-15.7%
23.3%
14.9%
14.6%
12.4%
18.1%
17.0%
9.0%
17.0%
Operating Income
-903.4
-692.4
-466.9
9.9
123.2
635.2
1,197.6
2,856.3
2,782.1
4,151.6
Operating Income % Chg.
-
23.4%
32.6%
-
1140.4%
415.4%
88.5%
138.5%
-2.6%
56.7%
Operating Income Margin
-74.5%
-119.3%
-45.2%
0.6%
5.0%
20.8%
28.8%
46.0%
36.7%
47.7%
Operating Income Margin % Chg.
-
60.0%
62.1%
-
748.4%
320.8%
38.0%
60.0%
-20.2%
28.4%
Total Other Income/Expenses Net
-72.7
-42.5
-90.9
-77.3
-138.9
-34.9
197.4
260.5
-51.7
-125.1
Total Other Income/Expenses Net % Chg.
393.9%
41.6%
114.1%
15.0%
79.7%
74.9%
-
32.0%
-
-
Income Before Tax
-976.1
-734.9
-557.8
-67.4
-15.7
600.2
1,394.9
3,116.8
2,730.4
4,026.6
Income Before Tax % Chg.
7784.0%
24.7%
24.1%
87.9%
76.7%
-
132.4%
123.4%
-12.4%
46.5%
Income Before Tax Margin
-80.5%
-126.6%
-54.0%
-4.0%
-0.6%
19.7%
33.5%
50.2%
36.0%
46.3%
Income Before Tax Margin % Chg.
9833.5%
57.2%
57.3%
92.7%
84.1%
-
70.1%
49.9%
-28.2%
20.1%
Income Tax Expense
-288.6
7.0
30.4
16.7
-107.3
-1,486.9
218.1
405.2
388.3
753.3
Income Tax Expense % Chg.
-
-
336.6%
-45.1%
-
1285.4%
-
85.8%
-4.2%
31.7%
Net Income
-445.0
-738.6
-556.3
-112.1
263.5
2,096.9
1,176.8
2,711.6
2,342.1
3,273.2
Net Income % Chg.
315.8%
66.0%
24.7%
79.9%
-
695.8%
-43.9%
130.4%
-13.6%
50.4%
Net Income Margin
-36.7%
-127.2%
-53.9%
-6.6%
10.6%
68.8%
28.3%
43.7%
30.9%
37.6%
Net Income Margin % Chg.
423.9%
246.5%
57.6%
87.8%
-
549.9%
-58.9%
54.6%
-29.2%
23.3%
Weighted Avg. Shares Out
224.9
235.3
241.3
244.7
248.9
254.3
256.7
259.8
257.7
255.5
Weighted Avg. Shares Out % Chg.
6.1%
4.6%
2.6%
1.4%
1.7%
2.2%
1.0%
1.2%
-0.8%
-1.4%
EPS
-2.0
-3.1
-2.3
-0.5
1.1
8.2
4.6
10.4
9.1
12.8
EPS % Chg.
296.0%
58.6%
26.4%
80.1%
-
677.4%
-44.4%
127.9%
-12.9%
52.5%
Weighted Avg. Shares Out Dil
224.9
235.3
241.3
244.7
253.2
259.2
260.7
263.4
259.9
258.3
Weighted Avg. Shares Out Dil % Chg.
6.1%
4.6%
2.6%
1.4%
3.5%
2.4%
0.6%
1.0%
-1.3%
-1.2%
EPS Diluted
-2.0
-3.1
-2.3
-0.5
1.0
8.1
4.5
10.3
9.0
12.7
EPS Diluted % Chg.
296.0%
58.6%
26.4%
80.1%
-
677.9%
-44.3%
128.2%
-12.4%
52.2%
Interest Income
-
-
-
-
-
-
63.7
22.2
4.9
59.8
Interest Income % Chg.
-
-
-
-
-
-
-
-65.1%
-78.0%
890.8%
Interest Expense
22.7
72.9
84.2
81.4
57.6
34.1
58.5
58.2
61.5
58.3
Interest Expense % Chg.
36.5%
220.6%
15.6%
-3.3%
-29.3%
-40.7%
71.5%
-0.6%
5.8%
-7.0%
EBIT
-998.8
-807.7
-642.0
-148.8
-73.2
566.1
1,400.1
3,080.9
2,673.8
4,028.1
EBIT % Chg.
3586.6%
19.1%
20.5%
76.8%
50.8%
-
147.3%
120.0%
-13.2%
49.7%
EBIT Margin
-82.4%
-139.2%
-62.2%
-8.7%
-2.9%
18.6%
33.6%
49.6%
35.3%
46.3%
EBIT Margin % Chg.
4545.0%
68.9%
55.3%
85.9%
66.3%
-
81.1%
47.6%
-28.9%
22.6%
Depreciation & Amortization
48.4
63.3
62.3
61.4
61.4
72.4
106.9
109.5
125.6
143.7
Depreciation & Amortization % Chg.
26.6%
30.8%
-1.4%
-1.5%
-0.0%
18.0%
47.7%
2.4%
14.7%
18.7%
EBITDA
-950.5
-744.5
-579.7
-87.4
-11.8
638.5
1,507.0
3,190.4
2,799.4
4,171.8
EBITDA % Chg.
-
21.7%
22.1%
84.9%
86.5%
-
136.0%
111.7%
-12.3%
48.3%
EBITDA Margin
-78.4%
-128.3%
-56.2%
-5.1%
-0.5%
21.0%
36.2%
51.4%
37.0%
47.9%
EBITDA Margin % Chg.
-
63.6%
56.2%
90.9%
90.7%
-
72.8%
42.0%
-28.1%
21.5%